1
|
Cahill ME, Lozoya SB, Griffin MA, Blackstock A, Stockdale K, Cowman S, Graff R, Spear C, Carter K. Observed face mask use outside retail chain stores during the COVID-19 pandemic in two cities in the state of Idaho, USA. J Community Health 2024; 49:26-33. [PMID: 37314630 PMCID: PMC10719412 DOI: 10.1007/s10900-023-01241-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 05/29/2023] [Indexed: 06/15/2023]
Abstract
During the COVID-19 pandemic, public health authorities have encouraged the use of face masks to minimize transmission within the community. To assess mask wear during a COVID-19 surge and guide public health response efforts, including public messaging on mask recommendations, we compared observed mask use in the largest city in each of Idaho's 2 most populous counties, both without a current mask mandate. We recorded mask usage by every third person exiting stores of 5 retail chains in Boise and Nampa during November 8-December 5, 2021. Observations were conducted during three time periods (morning, afternoon, and evening) on weekday and weekend days. A multivariable model with city, retail chain, and city-chain interaction was used to assess mask wear differences by city for each chain. Of 3021 observed persons, 22.0% wore masks. In Boise, 31.3% (430/1376) of observed persons wore masks; in Nampa, 14.3% (236/1645) wore masks. Among all persons wearing masks, > 94% wore masks correctly; cloth and surgical masks were most common. By retail chain, observed individuals at Boise locations were 2.3-5.7 times as likely to wear masks than persons at respective Nampa locations. This study provided a rapid, nonconfrontational assessment of public use of mitigation measures in 2 Idaho cities during a COVID-19 surge.
Collapse
Affiliation(s)
- Megan E Cahill
- Division of Public Health, Idaho Department of Health Welfare, Boise, ID, USA.
- Epidemic Intelligence Service, Division of Scientific Education and Professional Development, Centers for Disease Control and Prevention, Atlanta, GA, USA.
| | - Sujeith Barraza Lozoya
- Division of Public Health, Idaho Department of Health Welfare, Boise, ID, USA
- Public Health Associate Program, Centers for Disease Control and Prevention, Atlanta, GA, USA
| | - Michelle A Griffin
- Division of Public Health, Idaho Department of Health Welfare, Boise, ID, USA
| | - Anna Blackstock
- Epidemiology Workforce Branch, Centers for Disease Control and Prevention, Atlanta, GA, USA
| | | | | | - Robert Graff
- Division of Public Health, Idaho Department of Health Welfare, Boise, ID, USA
| | | | - Kris Carter
- Division of Public Health, Idaho Department of Health Welfare, Boise, ID, USA
- Center for Preparedness and Response, Centers for Disease Control and Prevention, Atlanta, GA, USA
| |
Collapse
|
2
|
Song T, Chen C, Bao S, Du B, Wang X, Liu J, Wang F, Ma W, Yao G, Wan X, Zhang X, Wang J, Jiang H. An immobilization-based, loop-mediated isothermal amplification device for nucleic acid detection of SARS-CoV-2 N gene. BIOTECHNOL BIOTEC EQ 2022. [DOI: 10.1080/13102818.2022.2134822] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/02/2023] Open
Affiliation(s)
- Tianyu Song
- State Key Laboratory of NBC Protection for Civilian, Beijing, PR China
| | - Chang Chen
- State Key Laboratory of NBC Protection for Civilian, Beijing, PR China
| | - Shaoheng Bao
- State Key Laboratory of NBC Protection for Civilian, Beijing, PR China
| | - Bin Du
- State Key Laboratory of NBC Protection for Civilian, Beijing, PR China
| | - Xiaokun Wang
- State Key Laboratory of NBC Protection for Civilian, Beijing, PR China
| | - Jiajia Liu
- State Key Laboratory of NBC Protection for Civilian, Beijing, PR China
| | - Fuli Wang
- State Key Laboratory of NBC Protection for Civilian, Beijing, PR China
| | - Wei Ma
- State Key Laboratory of NBC Protection for Civilian, Beijing, PR China
| | - Ge Yao
- State Key Laboratory of NBC Protection for Civilian, Beijing, PR China
| | - Xiukun Wan
- State Key Laboratory of NBC Protection for Civilian, Beijing, PR China
| | - Xinlong Zhang
- State Key Laboratory of NBC Protection for Civilian, Beijing, PR China
| | - Jingjing Wang
- State Key Laboratory of NBC Protection for Civilian, Beijing, PR China
| | - Hui Jiang
- State Key Laboratory of NBC Protection for Civilian, Beijing, PR China
| |
Collapse
|
3
|
Dolatshahi Z, Nargesi S, Sadeghifar J, Mezginejad F, Jafari A, Bazyar M, Ghafourian S, Sani'ee N. Economic evaluation of laboratory diagnostic test types in Covid-19 epidemic: A systematic review. Int J Surg 2022; 105:106820. [PMID: 35987335 PMCID: PMC9384461 DOI: 10.1016/j.ijsu.2022.106820] [Citation(s) in RCA: 5] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/11/2022] [Revised: 07/24/2022] [Accepted: 07/30/2022] [Indexed: 11/25/2022]
Abstract
Background Corona 2 virus (SARS-CoV-2) is known as the causative agent of COVID-19 disease; the World Health Organization (WHO) declared it an epidemic on March 11, 2020. The Joint Guidelines of the Centers for Disease Control and Prevention (CDC) and the WHO including social distancing, the use of face masks, emphasis on hand washing, quarantine, and using diagnosis tests have been used widely, but the value of diagnostic interventions to prevent the transmission of SARS-CoV-2 is unclear. We compared the economic evaluation of different laboratory diagnostic interventions with each other and also with implementing the conservative CDC & WHO guidelines. Material and methods Electronic searches were conducted on PubMed, Embase, Science Direct, Scopus, Cochrane Library, Web of Knowledge, NHSEED, NHS Health Technology assessment (CRD), and Cost-Effectiveness Analysis Registry databases. Related articles were reviewed from January 2020 to the end of November 2021. Results Out of 1791 initial studies, 13 articles had the inclusion criteria. According to the Consolidated Health Economic Evaluation Reporting Standards (CHEERS) checklist, ten studies were of excellent quality, and the remaining two studies were of very good quality. Most studies were cost-effectiveness analysis studies. The entered studies had different time horizons. Diagnostic tests reviewed in the studies included real-time polymerase chain reaction (RT-PCR) test, immunoglobulin G (IgG) & Antigen, point of care tests. Although polymerase chain reaction (PCR) testing improves the quality of life and survival for patients with infected Covid-19 based on its greater effectiveness compared to standard protection protocols, due to the high cost of this intervention, it has been considered a cost-effective method in some countries. Conclusion Since most studies have been conducted in developed countries, it unquestionably does not make sense to extend these results to low-income and developing countries. Therefore further studies are required in low-income and developing countries to evaluate the cost-effectiveness of laboratory-based diagnostic methods (RT-PCR) of covid-19 in variable prevalence of infectious cases.
Collapse
Affiliation(s)
- Zeinab Dolatshahi
- Department of Health Policy, School of Health Management and Information Sciences, Iran University of Medical Sciences, Tehran, Iran
| | - Shahin Nargesi
- Department of Health Management and Economics, Faculty of Health, Ilam University of Medical Sciences, Ilam, Iran.
| | - Jamil Sadeghifar
- Department of Health Management and Economics, Faculty of Health, Ilam University of Medical Sciences, Ilam, Iran
| | - Fateme Mezginejad
- Cellular and Molecular Research Center, Birjand University of Medical Sciences, Birjand, Iran
| | - Abdosaleh Jafari
- Health Human Resources Research Center, School of Health Management and Information Sciences, Shiraz University of Medical Sciences, Shiraz, Iran
| | - Mohammad Bazyar
- Department of Health Management and Economics, Faculty of Health, Ilam University of Medical Sciences, Ilam, Iran
| | - Sobhan Ghafourian
- Department of Microbiology, Faculty of Medicine, Ilam University of Medical Sciences, Ilam, Iran
| | - Nadia Sani'ee
- Ph.D. in Medical Library and Information Science, Spiritual Health Research Center, Iran University of Medical Sciences, Tehran, Iran
| |
Collapse
|
4
|
Zhou L, Yan W, Li S, Yang H, Zhang X, Lu W, Liu J, Wang Y. Cost-effectiveness of interventions for the prevention and control of COVID-19: Systematic review of 85 modelling studies. J Glob Health 2022; 12:05022. [PMID: 35712857 PMCID: PMC9196831 DOI: 10.7189/jogh.12.05022] [Citation(s) in RCA: 12] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/13/2022] Open
Abstract
Background We aimed to quantitatively summarise the health economic evaluation evidence of prevention and control programs addressing COVID-19 globally. Methods We did a systematic review and meta-analysis to assess the economic and health benefit of interventions for COVID-19. We searched PubMed, Embase, Web of Science, and Cochrane Library of economic evaluation from December 31, 2019, to March 22, 2022, to identify relevant literature. Meta-analyses were done using random-effects models to estimate pooled incremental net benefit (INB). Heterogeneity was assessed using I2 statistics and publication bias was assessed by Egger's test. This study is registered with PROSPERO, CRD42021267475. Results Of 16 860 studies identified, 85 articles were included in the systematic review, and 25 articles (10 studies about non-pharmacological interventions (NPIs), five studies about vaccinations and 10 studies about treatments) were included in the meta-analysis. The pooled INB of NPIs, vaccinations, and treatments were $1378.10 (95% CI = $1079.62, $1676.59), $254.80 (95% CI = $169.84, $339.77) and $4115.11 (95% CI = $1631.09, $6599.14), respectively. Sensitivity analyses showed similar findings. Conclusions NPIs, vaccinations, and treatments are all cost-effective in combating the COVID-19 pandemic. However, evidence was mostly from high-income and middle-income countries. Further studies from lower-income countries are needed.
Collapse
Affiliation(s)
- Lihui Zhou
- School of Public Health, Tianjin Medical University, Tianjin, China
| | - Wenxin Yan
- Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing, China
| | - Shu Li
- School of Management, Tianjin University of Traditional Chinese Medicine, Tianjin, China
| | - Hongxi Yang
- School of Basic Medical Sciences, Tianjin Medical University, Tianjin, China
| | - Xinyu Zhang
- School of Public Health, Tianjin Medical University, Tianjin, China
| | - Wenli Lu
- School of Public Health, Tianjin Medical University, Tianjin, China
| | - Jue Liu
- Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing, China
- Institute for Global Health and Development, Peking University, Beijing, China
| | - Yaogang Wang
- School of Public Health, Tianjin Medical University, Tianjin, China
- Health Science and Engineering College, Tianjin University of Traditional Chinese Medicine, Tianjin, China
| |
Collapse
|
5
|
Inclusive health: modeling COVID-19 in correctional facilities and communities. BMC Public Health 2022; 22:982. [PMID: 35578258 PMCID: PMC9108375 DOI: 10.1186/s12889-022-13313-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/20/2021] [Accepted: 04/06/2022] [Indexed: 11/26/2022] Open
Abstract
Background Mass incarceration, commonly associated with overcrowding and inadequate health resources for incarcerated people, creates a fertile environment for the spread of the coronavirus disease 2019 (COVID-19) in U.S. correctional facilities. The exact role that correctional facilities play in enhancing COVID-19 spread and enabling community re-emergence of COVID-19 is unknown. Methods We constructed a novel stochastic model of COVID-19 transmission to estimate the impact of correctional facilities, specifically jails and state prisons, for enhancing disease transmission and enabling disease re-emergence in local communities. Using our model, we evaluated scenarios of testing and quarantining infected incarcerated people at 0.0, 0.5, and 1.0 times the rate that occurs for infected people in the community for population sizes of 5, 10, and 20 thousand people. Results Our results illustrate testing and quarantining an incarcerated population of 800 would reduce the probability of a major outbreak in the local community. In addition, testing and quarantining an incarcerated population would prevent between 10 to 2640 incidences of COVID-19 per year, and annually save up to 2010 disability-adjusted life years, depending on community size. Conclusions Managing COVID-19 in correctional facilities is essential to mitigate risks to community health, and thereby stresses the importance of improving the health standards of incarcerated people. Supplementary Information The online version contains supplementary material available at 10.1186/s12889-022-13313-7.
Collapse
|